Correction to: A Phase I Study to Evaluate the Pharmacokinetics and Safety of Lorlatinib in Adults with Mild, Moderate, and Severe Renal Impairment

Eur J Drug Metab Pharmacokinet. 2022 May;47(3):441. doi: 10.1007/s13318-022-00759-8.
No abstract available

Publication types

  • Published Erratum